Save your place

Sign in to WhoBought

Please try again later.

Axsome Therapeutics, Inc. (AXSM) institutional ownership

Latest close $221.64 Jul 20, 2026
Market cap$5.1B 52-week range SectorHealthcare
Funds holding · Q1 2026
397
reported AXSM position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
205 buyers · 192 sellers

Axsome Therapeutics, Inc. (AXSM) price and institutional activity

Dates

Q1 2026

$0 bought by 205 investors
First Trust Advisors LPPoint72 Asset Management, L.P. +203 more
$0 sold by 192 investors
Rtw Investments, LPNorges +190 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Axsome Therapeutics, Inc. (AXSM) institutional activity · 397

Investor Type Est. change Change Δ Own Date
Rtw Investments, LP · Exited
Change −888K Δ Own −100.0% Date Q1 2026
Rtw Investments, LP Exited· Q1 2026 −888K −100.0% Q1 2026
First Trust Advisors LP · Added
Change +534K Date Q1 2026
First Trust Advisors LP Added· Q1 2026 +534K Q1 2026
Norges · Exited
Change −495K Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −495K −100.0% Q1 2026
Point72 Asset Management, L.P. · Added
Change +407K Δ Own +2259.9% Date Q1 2026
Point72 Asset Management, L.P. Added· Q1 2026 +407K +2259.9% Q1 2026
Assenagon Asset Management S.A. · Added
Change +398K Date Q1 2026
Assenagon Asset Management S.A. Added· Q1 2026 +398K Q1 2026
FMR LLC · Added
Change +385K Δ Own +32.6% Date Q1 2026
FMR LLC Added· Q1 2026 +385K +32.6% Q1 2026
Adage Capital Partners Gp, L.L.C. · Added
Change +370K Date Q1 2026
Adage Capital Partners Gp, L.L.C. Added· Q1 2026 +370K Q1 2026
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. · Exited
Change −279K Δ Own −100.0% Date Q1 2026
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. Exited· Q1 2026 −279K −100.0% Q1 2026
Vestal Point Capital, LP · Exited
Change −210K Δ Own −100.0% Date Q1 2026
Vestal Point Capital, LP Exited· Q1 2026 −210K −100.0% Q1 2026
Sofinnova Investments, Inc. · Added
Change +200K Date Q1 2026
Sofinnova Investments, Inc. Added· Q1 2026 +200K Q1 2026
T. Rowe Price Associates · Reduced
Change −193K Date Q1 2026
T. Rowe Price Associates Reduced· Q1 2026 −193K Q1 2026
UBS Group AG · Added
Change +192K Date Q1 2026
UBS Group AG Added· Q1 2026 +192K Q1 2026
Two Sigma Advisers, LP · Exited
Change −188K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −188K −100.0% Q1 2026
Vanguard · Added
Change +188K Date Q1 2026
Vanguard Added· Q1 2026 +188K Q1 2026
Marshall Wace, LLP · Reduced
Change −179K Date Q1 2026
Marshall Wace, LLP Reduced· Q1 2026 −179K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 397

Famous investor activity in Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics, Inc. (AXSM) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Tabuteau Herriot · Director Sell −$12M
Price $240.25 Qty −50K Owned 7K ΔOwn −87.3% Trade date Jul 1, 2026 Filed date Jul 1, 2026
Tabuteau Herriot Director Sell $240.25 −50K −$12M 7K −87.3% Jul 1, 2026 Jul 1, 2026
Tabuteau Herriot · Director 2 operations 0
Price $4.95 Owned 50K Trade date Jul 1, 2026 Filed date Jul 1, 2026
Tabuteau Herriot Director 2 operations $4.95 0 50K Jul 1, 2026 Jul 1, 2026
Jeffs Roger · Director Sell −$71K
Price $249.12 Qty −286 Owned 58K Trade date Jun 11, 2026 Filed date Jun 11, 2026
Jeffs Roger Director Sell $249.12 −286 −$71K 58K Jun 11, 2026 Jun 11, 2026
Jeffs Roger · Director Sell −$70K
Price $246.18 Qty −286 Owned 59K Trade date Jun 10, 2026 Filed date Jun 11, 2026
Jeffs Roger Director Sell $246.18 −286 −$70K 59K Jun 10, 2026 Jun 11, 2026
Mahony Susan · Director Sell −$74K
Price $246.18 Qty −300 Owned 829 Trade date Jun 10, 2026 Filed date Jun 10, 2026
Mahony Susan Director Sell $246.18 −300 −$74K 829 Jun 10, 2026 Jun 10, 2026
Coleman Mark · Director Sell −$160K
Price $249.00 Qty −643 Owned 30K Trade date Jun 10, 2026 Filed date Jun 10, 2026
Coleman Mark Director Sell $249.00 −643 −$160K 30K Jun 10, 2026 Jun 10, 2026
Mahony Susan · Director Sell −$71K
Price $237.21 Qty −300 Owned 1K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Mahony Susan Director Sell $237.21 −300 −$71K 1K Jun 9, 2026 Jun 10, 2026
Tabuteau Herriot · Director Sell −$12M
Price $241.01 Qty −50K Owned 7K Trade date Jun 9, 2026 Filed date Jun 9, 2026
Tabuteau Herriot Director Sell $241.01 −50K −$12M 7K Jun 9, 2026 Jun 9, 2026
Tabuteau Herriot · Director 2 operations 0
Price $4.95 Owned 99K Trade date Jun 9, 2026 Filed date Jun 9, 2026
Tabuteau Herriot Director 2 operations $4.95 0 99K Jun 9, 2026 Jun 9, 2026
Pizzie Nick · CFO Sell −$7.9M
Price $240.09 Qty −33K Owned 43K Trade date Jun 9, 2026 Filed date Jun 9, 2026
Pizzie Nick CFO Sell $240.09 −33K −$7.9M 43K Jun 9, 2026 Jun 9, 2026
Pizzie Nick · CFO 2 operations 0
Price $3.50 Owned 72K Trade date Jun 9, 2026 Filed date Jun 9, 2026
Pizzie Nick CFO 2 operations $3.50 0 72K Jun 9, 2026 Jun 9, 2026
Jeffs Roger · Director 2 operations 0
Owned 0 Trade date Jun 8, 2026 Filed date Jun 10, 2026
Jeffs Roger Director 2 operations 0 0 Jun 8, 2026 Jun 10, 2026
Saad Mark E. · Director 2 operations 0
Owned 0 Trade date Jun 8, 2026 Filed date Jun 10, 2026
Saad Mark E. Director 2 operations 0 0 Jun 8, 2026 Jun 10, 2026
Mahony Susan · Director 2 operations 0
Owned 0 Trade date Jun 8, 2026 Filed date Jun 10, 2026
Mahony Susan Director 2 operations 0 0 Jun 8, 2026 Jun 10, 2026
Coleman Mark · Director 2 operations 0
Owned 0 Trade date Jun 8, 2026 Filed date Jun 10, 2026
Coleman Mark Director 2 operations 0 0 Jun 8, 2026 Jun 10, 2026
15 of 95
15 of 95 Sign in to continue to older insider transactions.

Axsome Therapeutics, Inc. (AXSM) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Rtw Investments, LP 4.5M
% of shares outstanding 9.5% Filing date Feb 14, 2024
Rtw Investments, LP 4.5M 9.5% Feb 14, 2024
Vanguard Group Inc 3.7M
% of shares outstanding 7.8% Filing date Feb 13, 2024
Vanguard Group Inc 3.7M 7.8% Feb 13, 2024
BlackRock Inc. 3.2M
% of shares outstanding 6.8% Filing date Jan 26, 2024
BlackRock Inc. 3.2M 6.8% Jan 26, 2024
Fairmount Funds Management LLC 2.4M
% of shares outstanding 4.9% Filing date Feb 14, 2024
Fairmount Funds Management LLC 2.4M 4.9% Feb 14, 2024
Pfm Health Sciences, LP 1.4M
% of shares outstanding 3.2% Filing date Feb 14, 2023
Pfm Health Sciences, LP 1.4M 3.2% Feb 14, 2023
Venrock Healthcare Capital Partners Ii, L.P.
% of shares outstanding 0.0% Filing date Feb 14, 2023
Venrock Healthcare Capital Partners Ii, L.P. 0.0% Feb 14, 2023
6 of 6

Axsome Therapeutics, Inc. (AXSM) ownership FAQ

Who owns AXSM?

397 reporting institutions disclosed AXSM position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.